$10.27
Live
0.58%
Downside
Day's Volatility :4.36%
Upside
3.79%
30.67%
Downside
52 Weeks Volatility :50.93%
Upside
29.22%
Period | Enhabit Inc | Index (Russel 2000) |
---|---|---|
3 Months | 2.59% | 0.0% |
6 Months | -3.2% | 0.0% |
1 Year | -28.69% | 0.0% |
3 Years | -54.75% | -20.2% |
Market Capitalization | 488.0M |
Book Value | $13.45 |
Earnings Per Share (EPS) | -1.65 |
Wall Street Target Price | 9.18 |
Profit Margin | -7.95% |
Operating Margin TTM | 4.92% |
Return On Assets TTM | 1.55% |
Return On Equity TTM | -10.98% |
Revenue TTM | 1.0B |
Revenue Per Share TTM | 20.88 |
Quarterly Revenue Growth YOY | -1.0% |
Gross Profit TTM | 545.5M |
EBITDA | 67.8M |
Diluted Eps TTM | -1.65 |
Quarterly Earnings Growth YOY | -0.92 |
EPS Estimate Current Year | 0.27 |
EPS Estimate Next Year | 0.34 |
EPS Estimate Current Quarter | 0.04 |
EPS Estimate Next Quarter | 0.05 |
What analysts predicted
Downside of 10.61%
FY19 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | - |
Net Income | 24.0M | - |
Net Profit Margin | 2.2% | - |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | ↓ 1.26% |
Net Income | 75.0M | ↑ 212.5% |
Net Profit Margin | 6.96% | ↑ 4.76% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | ↑ 2.63% |
Net Income | 111.1M | ↑ 48.13% |
Net Profit Margin | 10.04% | ↑ 3.08% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | ↓ 2.12% |
Net Income | 62.5M | ↓ 43.74% |
Net Profit Margin | 5.77% | ↓ 4.27% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 1.0B | ↓ 3.4% |
Net Income | -80.5M | ↓ 228.8% |
Net Profit Margin | -7.69% | ↓ 13.46% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 275.1M | ↑ 3.54% |
Net Income | 7.7M | ↓ 10.47% |
Net Profit Margin | 2.8% | ↓ 0.44% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 275.1M | ↑ 0.0% |
Net Income | 7.7M | ↑ 0.0% |
Net Profit Margin | 2.8% | ↑ 0.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 262.3M | ↓ 4.65% |
Net Income | -74.4M | ↓ 1066.23% |
Net Profit Margin | -28.36% | ↓ 31.16% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 258.3M | ↓ 1.52% |
Net Income | -2.4M | ↓ 96.77% |
Net Profit Margin | -0.93% | ↑ 27.43% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 260.6M | ↑ 0.89% |
Net Income | -6.4M | ↑ 166.67% |
Net Profit Margin | -2.46% | ↓ 1.53% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 262.4M | ↑ 0.69% |
Net Income | 200.0K | ↓ 103.12% |
Net Profit Margin | 0.08% | ↑ 2.54% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 1.6B | - |
Total Liabilities | 227.0M | - |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 1.7B | ↑ 6.38% |
Total Liabilities | 236.7M | ↑ 4.27% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 1.6B | ↓ 4.33% |
Total Liabilities | 767.3M | ↑ 224.17% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 1.5B | ↓ 10.89% |
Total Liabilities | 764.7M | ↓ 0.34% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↑ 1.4% |
Total Liabilities | 772.6M | ↑ 615.37% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↑ 0.0% |
Total Liabilities | 767.3M | ↓ 0.69% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.4B | ↓ 13.33% |
Total Liabilities | 719.0M | ↓ 6.29% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.5B | ↑ 1.73% |
Total Liabilities | 742.1M | ↑ 3.21% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.5B | ↑ 1.07% |
Total Liabilities | 764.7M | ↑ 3.05% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 1.4B | ↓ 1.45% |
Total Liabilities | 740.2M | ↓ 3.2% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 59.5M | - |
Investing Cash Flow | -246.0M | - |
Financing Cash Flow | 198.2M | - |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 24.9M | ↓ 58.15% |
Investing Cash Flow | -3.0M | ↓ 98.78% |
Financing Cash Flow | -16.7M | ↓ 108.43% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 123.3M | ↑ 395.18% |
Investing Cash Flow | -119.2M | ↑ 3873.33% |
Financing Cash Flow | -36.1M | ↑ 116.17% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 80.1M | ↓ 35.04% |
Investing Cash Flow | -42.3M | ↓ 64.51% |
Financing Cash Flow | -18.6M | ↓ 48.48% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 4.1M | ↑ 310.0% |
Investing Cash Flow | -38.2M | ↑ 6266.67% |
Financing Cash Flow | 13.4M | ↓ 316.13% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 4.1M | ↑ 0.0% |
Investing Cash Flow | -3.2M | ↓ 91.62% |
Financing Cash Flow | 13.4M | ↑ 0.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 9.6M | ↑ 134.15% |
Investing Cash Flow | -800.0K | ↓ 75.0% |
Financing Cash Flow | -11.9M | ↓ 188.81% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 6.3M | ↓ 34.37% |
Investing Cash Flow | -1.8M | ↑ 125.0% |
Financing Cash Flow | -5.8M | ↓ 51.26% |
Sell
Neutral
Buy
Enhabit Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Enhabit Inc | 21.2% | -3.2% | -28.69% | -54.75% | -54.75% |
![]() Fresenius Medical Care Ag | 6.75% | 1.59% | -22.77% | -49.63% | -45.76% |
![]() Hca Holdings, Inc. | 3.62% | 24.47% | 25.02% | 43.55% | 143.2% |
![]() Tenet Healthcare Corp. | 10.35% | 80.65% | 95.1% | 108.93% | 580.33% |
![]() Universal Health Services Inc. | 8.08% | 30.09% | 44.94% | 32.59% | 34.96% |
![]() Davita Healthcare Partners Inc. | 0.24% | 32.97% | 40.81% | 19.01% | 139.9% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Enhabit Inc | 9.84 | NA | NA | 0.27 | -0.11 | 0.02 | NA | 13.45 |
![]() Fresenius Medical Care Ag | 22.58 | 22.58 | 0.39 | 1.5 | 0.05 | 0.03 | 0.03 | 47.4 |
![]() Hca Holdings, Inc. | 16.16 | 16.16 | 1.44 | 21.86 | 0.74 | 0.11 | 0.01 | -6.06 |
![]() Tenet Healthcare Corp. | 5.46 | 5.46 | 1.74 | 8.98 | 0.54 | 0.07 | NA | 16.09 |
![]() Universal Health Services Inc. | 15.8 | 15.8 | 1.87 | 13.79 | 0.13 | 0.06 | 0.0 | 93.48 |
![]() Davita Healthcare Partners Inc. | 16.31 | 16.31 | 1.16 | 9.32 | 0.43 | 0.06 | NA | 10.56 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Enhabit Inc | Hold | $488.0M | -54.75% | 9.84 | -7.95% |
![]() Fresenius Medical Care Ag | Hold | $11.9B | -45.76% | 22.58 | 2.48% |
![]() Hca Holdings, Inc. | Buy | $90.1B | 143.2% | 16.16 | 8.4% |
![]() Tenet Healthcare Corp. | Buy | $14.6B | 580.33% | 5.46 | 12.54% |
![]() Universal Health Services Inc. | Hold | $12.4B | 34.96% | 15.8 | 5.57% |
![]() Davita Healthcare Partners Inc. | Hold | $12.6B | 139.9% | 16.31 | 6.61% |
Insights on Enhabit Inc
Revenue is up for the last 3 quarters, 258.3M → 262.39M (in $), with an average increase of 0.8% per quarter
Netprofit is up for the last 2 quarters, -6.4M → 200.0K (in $), with an average increase of 3300.0% per quarter
In the last 1 year, Tenet Healthcare Corp. has given 95.1% return, outperforming this stock by 123.8%
BlackRock Inc
Deerfield Management Co
Vanguard Group Inc
AREX CAPITAL MANAGEMENT, LP
Jana Partners Management LP
State Street Corporation
Organization | Enhabit Inc |
Employees | 10800 |
CEO | Ms. Barbara Ann Jacobsmeyer B.S., M.A., P.T. |
Industry | Healthcare |